Magwate, Rayza L.
HRN: 22-45-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2023
01/14/2023
IV
1g
Q6hours
URTI; Severe Anemia
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes